Participants were randomized to double-blind treatment with low-dose oral @-estradiol ( @ mg/d ) ( n = @ ) , low-dose venlafaxine hydrochloride extended release ( @ mg/d ) ( n = @ ) , or placebo ( n = @ ) for @ weeks .